CKD and Nephrotic Syndrome Flashcards

1
Q

Leading cause of ESRD

A

Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Components that increase risk of mortality with CKD

A

DM, CVD, & CKD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most likely to get CKD

A

Black females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CKD Definition

A

Decreased kidney function OR kidney damage for 3 or more months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical evidence CKD

A
  1. GFR <60

2. Evidence of kidney damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Evidence of kidney damage

A
  1. Albuminuria - Urine albumin-to-Cr ratio >30*
  2. Abnormal imaging test
  3. Abnormal urinary sediment
  4. History of kidney transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Best marker for kidney function

A

GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Poor measure of kidney function

A

Serum creatinine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hallmark of progressive kidney disease

A

Declining GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Staging CKD

A
Based on GFR:
G1. >90
G2. 60-89
G3a. 45-59
G3b. 30-44
G4. 15-29
G5. <15 (Kidney failure - Add "D" if treated by dialysis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is classification of CKD based on?

A

Cause, GFR, and albuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Classifying CKD

A

Stage A1) ACR<30; neg to trace protein dipstick
Stage A2) ACR 30-300; trace to 1+ protein dipstick
Stage A3) ACR>300; >1+ protein dipstick

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Low risk of CKD progression

A

A1 with G1 or G2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mod risk of CKD progression

A

1) A1 with G3a

2) A2 with G1 or G2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

High risk of CKD progression

A

1) A1 with G3b
2) A2 with G3a
3) A3 with G1 or G2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Very high risk of CKD progression

A

1) A2 with G3b
2) A3 with G3a and G3b
3) ALL G4 and G5 (no matter the albumin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Progression of CKD

A

Destruction of nephrons&raquo_space;
Compensatory hypertrophy of working nephrons&raquo_space; Overwork of remaining nephrons&raquo_space;
Progressive glomerular sclerosis and fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Causes of CKD

A
DM*
HTN*
Glomerular disease
Polycystic kidney disease
Chronic tubulointerstitial disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Screening for CKD

A
  1. First determine risk for ALL patients
  2. At risk patients should be screened by checking: Urine albumin-to-creatinine ratio and serum creatinine to estimate GFR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Patients “at risk” for CKD

A
>60 YO
DM
HTN
CVD
FHx of kidney disease
Ethnic minority
Cancer
Systemic infection (HIV or Hep C)
Recurrent UTIs
Nephrolithiasis
Nephrotoxic drug exposure
Autoimmune disorders
History of AKI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Clinical Presentation of CKD

A

Depends on underlying cause and stage. Asymptomatic early and may not have symptoms until kidney failure is advanced!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Uremic syndrome

A

Accumulation of metabolic waste products typically seen with GFR <15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

S/Sx of uremic syndrome

A

Fatigue, malaise, pericarditis, encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Renal U/S findings for CKD

A

Small kidneys, bilaterally (<9-10cm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Leading cause of death in CKD patients

A

Cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Complications of CKD

A
CVD*
HTN
Dyslipidemia
Anemia
Mineral/Bone disorders
Fluid and electrolyte abnormalities
Uremia
Malnutrition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

CKD-MBD labs

A

Hyperphosphatemia, hypocalcemia, decreased Vitamin D - Secondary hyperparathyroidism*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

When is CKD-MBD clinically detectable

A

Stage 3 CKD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Important to managing CKD

A

Treat the underlying cause!

  • Glycemic control (if DM)
  • BP control (ACE or ARBs)
  • Weight management
  • Control CV factors (ie. lipids, smoking cessation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Slowing progression of proteinuric CKD

A

ACE or ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Caution of ACE and ARB

A

Acute reduction in GFR - Caution in AKI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Contraindication for ACE and ARB in CKD

A

Bilateral renal artery stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Target BP in CKD patients

A

W/out proteinuria - <140/90

W/ proteinuria - <130/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

When to refer CKD

A
GFR <30
Determine cause of CKD
Mange complications
Preparation/initiation of dialysis
Transplant eval
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

When to refer based on GFR and albumin classifications

A
  1. Always if ACR >300 (A3)
  2. Always if GFR <30 (G4 and G5)
  3. For all other patients, MONITOR (unless in low risk of progression - ACR <30 and GFR >60 (A1 with G1 or G2))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is renal replacement therapy (RRT)

A

Dialysis (hemo or peritoneal) or Kidney transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

RRT is used for

A

Patients with kidney failure/ESRD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Indications for dialysis

A

Uremic symptoms
Fluid overload refractory to diuresis
Refractory hyperkalemia, acidosis, hyperphosphatemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

When to start preparing for dialysis

A

GFR <30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Acute complications of hemodialysis

A
HYPOTENSION (25-55% of treatments)
Cramps
N/V
HA
CP
Back pain
Pruritus
Fever/chills
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Fluid used to “clean” the blood in dialysis

A

Dialysate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Complications of peritoneal dialysis

A

PERITONITIS
Exit site infection
Poor dialysate drainage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Treatment of choice for ESRD

A

Kidney transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Chronic Tubulointerstitial Disease

A

Interstitial scarring, fibrosis, and tubular atrophy –> progressive decrease in GFR (CKD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Underlying etiologies of chronic tubulointerstitial disease

A
Obstructive neuropathy
Reflux nephropathy
Analgesic nephropathy
Heavy metals (lead)
Lithium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

General findings of chronic tubulointerstitial disease

A

Polyuria (can’t concentrate urine secondary to damage)
Hyperkalemia (tubules become aldosterone resistant)
Urinalysis is nonspecific (proteinuria <2g/d, broad waxy casts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Obstructive uropathy definition

A

Prolonged obstruction of the urinary tract leads to:
1. Decreased GFR
2. Decreased renal blood flow
3. Impaired tubular function
Eventually leads to irreversible renal injury

48
Q

Causes of obstruction

A
Prostatic disease
Ureteral calculus in a single kidney
Bilateral ureteral calculi
Carcinoma of cervix, colon, or bladder
Retroperitoneal tumors or fibrosis
49
Q

Labs/Diagnostics for obstruction

A

UA, U/S

50
Q

UA findings with obstruction

A

Often BENIGN - may show hematuria, pyuria, or bacteriuria

51
Q

U/S findings with obstruction

A

Possible mass, hydroureter, hydronephrosis

52
Q

Cause of reflux nephropathy

A

Vesicoureteral reflux (VUR) or other urologic anomalies in early childhood. Leads to inflammation and fibrosis of kidney.

53
Q

Reflux nephropathy in kids

A

History of recurrent UTIs

54
Q

Reflux nephropathy in adults

A

Present with HTN

55
Q

Imaging for reflux nephropathy

A

U/S, VCUG

56
Q

U/S findings in reflux nephropathy

A

Renal scarring and hydronephrosis

57
Q

VCUG findings in reflux nephropathy

A

Often have VUR

58
Q

What is analgesic nephropathy

A

CKD caused by LONG-TERM consumption of analgesics (ie. acetaminophen, NSAIDS)

59
Q

Labs/diagnostics for analgesic nephropathy

A

UA, CT scan

60
Q

UA findings for analgesic nephropathy

A

Hematuria, mild proteinuria, sterile pyuria (WBC w/out bacteria)

61
Q

CT findings for analgesic nephropathy

A

Papillary microcalcifications/necrosis

62
Q

Treating chronic tubulointerstitial disease

A

Treat underlying cause and refer to nephrology or urology

63
Q

What is nephrotic syndrome

A

Noninflammatory damage to the glomerular capillary wall

64
Q

Nephrotic spectrum vs syndrome

A

Spectrum - Diseases that present primarily with proteinuria and a bland urine sediment (no cells or casts)
Syndrome - Distinct clinical and laboratory features of renal disease

65
Q

Clinical and lab features of nephrotic syndrome

A

Proteinuria (>3.5 g/d)
Hypoalbuminemia
Edema
Hyperlipidemia

66
Q

Nephrotic vs Nephritic (pathogenesis)

A

Nephrotic: Non-inflammatory
Nephritic: Inflammatory

67
Q

Nephrotic vs Nephritic (hematuria)

A

Nephrotic: +/-
Nephritic: ++

68
Q

Nephrotic vs Nephritic (proteinuria)

A

Nephrotic: >3.5 g/day
Nephritic: <3.0 g/day

69
Q

Nephrotic vs Nephritic (urine)

A

Nephrotic: “Foamy”/oval fat bodies*
Nephritic: Colar-colored urine; RBC casts

70
Q

Nephrotic vs Nephritic (edema)

A

Nephrotic: ++++
Nephritic: ++

71
Q

Cola-colored urine

A

Nephritic

72
Q

Foamy urine

A

Nephrotic

73
Q

Oval fat bodies

A

Nephrotic

74
Q

RBC casts

A

Nephritic

75
Q

Nephrotic syndrome primary etiologies

A
Minimal change disease (MCD)
Membranous nephropathy (MN)
Focal Segmental Glomerulosclerosis (FSGS)
76
Q

Nephrotic syndrome secondary etiologies

A

Diabetic nephropathy

Amyloidosis

77
Q

S/Sx of nephrotic syndrome

A
Edema
Ascites
"Foamy urine"
Malaise
Anorexia
Dyspnea
Weight gain
Orthostatic hypotension (hypovolemia)
78
Q

Anasarca

A

Massive, generalized edema

79
Q

Complications of nephrotic syndrome

A
HYPERCOAGULABILITY*
INFECTION*
Protein malnutrition
Vitamin D deficiency and hypocalcemia
Anemia
80
Q

Work-up for nephrotic syndrome

A
UA (ACR, proteinuria, lipiduria)
Urine microscopy (few cells/casts, OVAL FAT BODIES)
Serology
U/S
Biopsy if indicated
81
Q

Management of nephrotic syndrome

A
ACE/ARBs
Statins
Loops
Sodium/fluid restriction
Anticoagulants (when indicated)
Immunosuppressants (corticosteroids, cytotoxic agents)
Nephrology referral
82
Q

Most common cause of nephrotic syndrome in children

A

Minimal change disease (MCD)

83
Q

Causes of MCD

A
Most are IDIOPATHIC
Secondary MCD following: 
-URI* (esp in children)
-Hypersensitivity reactions (NSAIDs &amp; bee stings)
-Medications (lithium)
-Malignancies (hodgkins)
84
Q

MCD presentation

A

Sudden onset (days to week or two) of EDEMA

85
Q

MCD histopathology

A

No changes on light microscopy

Primarily effects the PODOCYTE

86
Q

MCD 1st line treatment

A

Prednisone

87
Q

MCD prognosis

A

Good (w/ treatment) - Very few progress to ESRD

88
Q

MN epidemiology

A

M>F; Adults - peak around 4th and 5th decades

89
Q

Primary MN causes

A

Most are IDIOPATHIC

Thought to be immune-mediated against podocytes

90
Q

Secondary MN causes

A
Hep B
Autoimmune diseases
Thyroiditis
Malignancy
Drugs
91
Q

Nephrotic syndrome with higher risk for hypercoagulable state

A

MN

92
Q

MN Presentation

A

Presents with features of nephrotic syndrome (80%):

  • GRADUAL development
  • Higher risk for hypercoagulable state
93
Q

Diagnosing MN

A

Serology, biopsy

94
Q

Treating MN

A

Supportive
+/- immunosuppressive agents
Transplant

95
Q

MN prognosis

A

Depends on renal function and amount of proteinuria

96
Q

Adverse risk factors for MN prognosis

A

Male, >50 YO

97
Q

Most common cause of PRIMARY glomerular diseases in adults

A

Focal Segmental Glomerulosclerosis (FSGS)

98
Q

Presentation of FSGS

A
VARIES a great deal
Nephrotic syndrome (>70%)
99
Q

FSGS Epidemiology

A

Black
Male
18-45 YO (no age group exempt)

100
Q

FSGS pathogenesis

A

Glomerular injury resulting from damage to PODOCYTES

101
Q

Cause of primary FSGS

A

Idiopathic

102
Q

Cause of secondary FSGS

A
Obesity
Infection
Inflammation
Toxins
Healed previous glomerular injury
Reflex nephropathy
103
Q

FSGS treatment

A

Supportive
Immunosuppressive agents (primary)
Disease-specific treatment (secondary)

104
Q

Adverse risk factors for FSGS prognosis

A

Nephrotic-range proteinuria (>3.5 g/day)
African-American
Renal insufficiency

105
Q

Most common cause of ESRD in the US

A

Diabetic Nephropathy

106
Q

Common comorbidity in Type I DM with nephropathy

A

Retinopathy

107
Q

Peak incidence diabetic nephropathy

A

DM for 10-20 years (esp if uncontrolled)

108
Q

Progression of diabetic nephropathy

A

Hyperfiltration»Albuminuria»Declined GFR

109
Q

Diabetic nephropathy treatment

A

Glycemic and BP control
ACE/ARBs
Statins (may add ezetimibe)
Dialysis and transplant (when indicated)

110
Q

Abnormally folded/shaped proteins

A

Amyloid

111
Q

Pathophysiology of Renal Amyloidosis

A

Deposition of amyloid in the GLOMERULUS

112
Q

AL Amyloidosis

A

Monoclonal light chain

113
Q

AA Amyloidosis

A

Chronic inflammatory disease (RA) or infection

114
Q

Presentation of renal amyloidosis

A

Proteinuria
Decreased GFR
Nephrotic syndrome

115
Q

Screening test for renal amyloidosis

A

Serum/urine protein electrophoresis (SPEP & UPEP)

116
Q

Renal amyloidosis prognosis

A

VARIES depending on the nature, number, and extent of other organ involvement

117
Q

Treatment for renal amyloidosis

A

Treat underlying cause

Refer to nephrology